---
title: "Lifeon Pharmaceutical plans to recover investment costs by transferring 2.22% equity in Mainowei"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239860624.md"
description: "According to the Zhitong Finance APP, Lifeon Pharmaceutical announced that its associate company, Nanjing Mainowei Pharmaceutical Technology Co., Ltd. (referred to as \"Mainowei\"), plans to recover its investment costs and intends to transfer 2.22% of Mainowei's equity, with a proposed transfer price of 22.1837 million yuan"
datetime: "2025-05-12T13:29:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239860624.md)
  - [en](https://longbridge.com/en/news/239860624.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239860624.md)
generator: "portal-rs"
---

# Lifeon Pharmaceutical plans to recover investment costs by transferring 2.22% equity in Mainowei

According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) announced that its affiliated company, Nanjing Mainowei Pharmaceutical Technology Co., Ltd. (referred to as "Mainowei"), plans to transfer 2.22% of its equity in Mainowei to recover investment costs, with a proposed transfer price of 22.1837 million yuan

### Related Stocks

- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)

## Related News & Research

- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)
- [RCS - ZAGENO - ZAGENO and ORO Labs Partnership](https://longbridge.com/en/news/297046609.md)
- [Abasca files NI 43-101 report backing Loki flake graphite resource update in Saskatchewan](https://longbridge.com/en/news/297313014.md)
- [Northstar Clean Tech wins new US patent for asphalt shingle reprocessing technology](https://longbridge.com/en/news/297153537.md)
- [Harmonychain Reaches Key Milestone in Lokotech ASIC Production](https://longbridge.com/en/news/297223350.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**